Juergen Wasem
Title
Cited by
Cited by
Year
Heart failure: the commonest reason for hospital admission in Germany: medical and economic perspectives
T Neumann, J Biermann, R Erbel, A Neumann, J Wasem, G Ertl, R Dietz
Deutsches Ärzteblatt International 106 (16), 269, 2009
2482009
Cost effectiveness of peginterferon α-2b plus ribavirin versus interferon α-2b plus ribavirin for initial treatment of chronic hepatitis C
U Siebert, G Sroczynski, S Rossol, J Wasem, U Ravens-Sieberer, ...
Gut 52 (3), 425-432, 2003
2292003
Risk adjustment and risk selection on the sickness fund insurance market in five European countries
WPMM Van de Ven, K Beck, F Buchner, D Chernichovsky, L Gardiol, ...
Health policy 65 (1), 75-98, 2003
2112003
Risk adjustment and risk selection in Europe: 6 years later
WPMM van de Ven, K Beck, C Van de Voorde, J Wasem, I Zmora
Health policy 83 (2-3), 162-179, 2007
1682007
Empirical standard costs for health economic evaluation in Germany--a proposal by the working group methods in health economic evaluation
C Krauth, F Hessel, T Hansmeier, J Wasem, R Seitz, B Schweikert
Gesundheitswesen (Bundesverband der Arzte des Offentlichen …, 2005
1592005
Zur Wirkung des Risikostrukturausgleichs in der gesetzlichen Krankenversicherung: Schriftenreihe des Bundesministeriums für Gesundheit und Soziale Sicherung. 140
K Jacobs, P Reschke, D Cassel, J Wasem
Baden-Baden: Nomos, 2002, 2002
1422002
Deutsche Empfehlungen zur gesundheitsökonomischen Evaluation-dritte und aktualisierte Fassung des Hannoveraner Konsens
JM Schulenburg, W Greiner, F Jost, N Klusen, M Kubin, R Leidl, ...
Gesundheitsökonomie und Qualitätsmanagement 12, 285-290, 2007
1372007
German recommendations on health economic evaluation: third and updated version of the Hanover Consensus
JM Graf von der Schulenburg, W Greiner, F Jost, N Klusen, M Kubin, ...
Value in health 11 (4), 539-544, 2008
1312008
Consumer price sensitivity and social health insurer choice in Germany and the Netherlands
FT Schut, S Greß, J Wasem
International Journal of Health Care Finance and Economics 3 (2), 117-138, 2003
1292003
Empirische Bewertungssätze in der gesundheitsökonomischen Evaluation-ein Vorschlag der AG Methoden der gesundheitsökonomischen Evaluation (AG MEG)
C Krauth, F Hessel, T Hansmeier, J Wasem, R Seitz, B Schweikert
Das Gesundheitswesen 67 (10), 736-746, 2005
1232005
Impact of 4 different definitions used for the assessment of the prevalence of the Metabolic Syndrome in primary healthcare: The German Metabolic and Cardiovascular Risk …
S Moebus, JU Hanisch, P Aidelsburger, P Bramlage, J Wasem, KH Jöckel
Cardiovascular diabetology 6 (1), 22, 2007
1192007
Free choice of sickness funds in regulated competition: evidence from Germany and the Netherlands
S Greß, P Groenewegen, J Kerssens, B Braun, J Wasem
Health policy 60 (3), 235-254, 2002
1132002
Needs for further improvement: risk adjustment in the German health insurance system
F Buchner, J Wasem
Health Policy 65 (1), 21-35, 2003
1032003
Krankenhaus-Report 2011: Schwerpunkt: Qualität durch Wettbewerb
J Klauber, M Geraedts, J Friedrich, J Wasem
Schattauer Verlag, 2011
101*2011
Krankenhaus-Report 2013
J Klauber, M Geraedts, J Friedrich, J Wasem
Schattauer Verlag, 2013
1002013
Dyslipidemia in primary care–prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS)
E Steinhagen-Thiessen, P Bramlage, C Lösch, H Hauner, H Schunkert, ...
Cardiovascular Diabetology 7 (1), 31, 2008
942008
Preconditions for efficiency and affordability in competitive healthcare markets: are they fulfilled in Belgium, Germany, Israel, the Netherlands and Switzerland?
WPMM Van de Ven, K Beck, F Buchner, E Schokkaert, FTE Schut, ...
Health policy 109 (3), 226-245, 2013
902013
Prognostic significance of FLT3 internal tandem duplication, nucleophosmin 1, and CEBPA gene mutations for acute myeloid leukemia patients with normal karyotype and younger …
M Port, M Böttcher, F Thol, A Ganser, R Schlenk, J Wasem, A Neumann, ...
Annals of hematology 93 (8), 1279-1286, 2014
882014
Economic Evaluation of Treatment Options in Patients with Alzheimer’s Disease
L Pouryamout, J Dams, J Wasem, R Dodel, A Neumann
Drugs 72 (6), 789-802, 2012
862012
Financial incentives for disease management programmes and integrated care in German social health insurance
S Greß, A Focke, F Hessel, J Wasem
Health Policy 78 (2-3), 295-305, 2006
812006
The system can't perform the operation now. Try again later.
Articles 1–20